Acura Pharmaceuticals, Inc. (ACUR) SEC News Oct. 24, 2025, 11:00 UTC (99% Neutral) ACURA PHARMACEUTICALS, INC. (ACUR) Files Form 8-K Full text
Register to leave comments News bot Oct. 24, 2025, 11:02 a.m. 📋 ACURA PHARMACEUTICALS, INC. (ACUR) - Other Event Filing Date: 2025-10-24 Accepted: 2025-10-24 07:00:50 Event Type: Other Event Event Details: Acura Pharmaceuticals, Inc. (ACUR) Provides Business Update Acura Pharmaceuticals, Inc. (ACUR) issued a business update covering recent developments. 🔍 Detailed Event Analysis: AI Summary: form_8k_exhibit EX-99. and Abuse Deterrent Pharma, LLC EXHIBIT 99.Key Elements Identified:Organizations: Times New Roman, Acura Pharmaceuticals, Inc., Times 💼 Business Developments: No business developments data available. Structured Data: Company Name: Acura Pharmaceuticals, Inc.CIK: 0000786947Ticker Symbol: ACURPeriod End Date: 2025-10-23Document Type: 8-K Search News categories Technical Exchange News(10264) Event(1436) SEC News(174039) FDA Approval(9602) Company Report(721) Business News(116860)
📋 ACURA PHARMACEUTICALS, INC. (ACUR) - Other Event
Filing Date: 2025-10-24
Accepted: 2025-10-24 07:00:50
Event Type: Other Event
Event Details:
🔍 Detailed Event Analysis:
AI Summary: form_8k_exhibit
Key Elements Identified:
💼 Business Developments:
No business developments data available.
Structured Data:
Search
News categories